This content is restricted.
Brief
"On March 14, 2025, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding Worsening of tensions in pegasys: new measurements and updated repository. The agency introduced a strict protocol to ensure patients without alternative therapies access treatment with peginterferon alfa-2a, while restricting its use for certain indications and co-infections due to stock limitations."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested